Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vidya Mave

Showing results (71-80 of 148) with videos related to

Pageof 15
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 8, 2025
A point-of-care prediction tool for recurrent tuberculosisSamyra R Cox, Aye Hnin Moe, Akshay N Gupte, et al.
Indian Journal of Medical Microbiology|March 18, 2017
High prevalence of cryptococcal antigenaemia amongst asymptomatic advanced HIV patients in Pune, IndiaDileep Kadam, Ajay Chandanwale, Renu Bharadwaj, et al.
Chest|September 29, 2022
Sex Differences in TB Clinical Presentation, Drug Exposure, and Treatment Outcomes in IndiaSona Deshmukh, Manasi Sane, Sanjay Gaikwad, et al.
Journal of Tropical Pediatrics|July 5, 2020
Mullen Scales of Early Learning Adaptation for Assessment of Indian Children and Application to Tuberculous MeningitisSmita Nimkar, Suvarna Joshi, Aarti Kinikar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2026
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trialsLindsay McKenna, Mike Frick, Valentina A Alarcón-Guizado, et al.
Plos One|February 13, 2023
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials GroupUmesh G Lalloo, Lauren Komarow, Judith A Aberg, et al.
Public Health Nutrition|March 5, 2019
Elevated highly sensitive C-reactive protein and d-dimer levels are associated with food insecurity among people living with HIV in Pune, IndiaSandesh Patil, Dileep Kadam, Nicky Mehtani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2024
Clinical Outcomes in Children With Human Immunodeficiency Virus Treated for Nonsevere Tuberculosis in the SHINE TrialChishala Chabala, Eric Wobudeya, Marieke M van der Zalm, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2018
Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis TreatmentOmamah Alfarisi, Vidya Mave, Sanjay Gaikwad, et al.
The Lancet. Global Health|June 8, 2026
Inclusion of young adolescents in policy development for new tuberculosis vaccinesMark Hatherill, Rebecca A Clark, Leonardo Martinez, et al.
Pageof 15

Showing results (71-80 of 148) with videos related to

Sort By:
Pageof 15
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 8, 2025
A point-of-care prediction tool for recurrent tuberculosisSamyra R Cox, Aye Hnin Moe, Akshay N Gupte, et al.
Indian Journal of Medical Microbiology|March 18, 2017
High prevalence of cryptococcal antigenaemia amongst asymptomatic advanced HIV patients in Pune, IndiaDileep Kadam, Ajay Chandanwale, Renu Bharadwaj, et al.
Chest|September 29, 2022
Sex Differences in TB Clinical Presentation, Drug Exposure, and Treatment Outcomes in IndiaSona Deshmukh, Manasi Sane, Sanjay Gaikwad, et al.
Journal of Tropical Pediatrics|July 5, 2020
Mullen Scales of Early Learning Adaptation for Assessment of Indian Children and Application to Tuberculous MeningitisSmita Nimkar, Suvarna Joshi, Aarti Kinikar, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 13, 2026
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trialsLindsay McKenna, Mike Frick, Valentina A Alarcón-Guizado, et al.
Plos One|February 13, 2023
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials GroupUmesh G Lalloo, Lauren Komarow, Judith A Aberg, et al.
Public Health Nutrition|March 5, 2019
Elevated highly sensitive C-reactive protein and d-dimer levels are associated with food insecurity among people living with HIV in Pune, IndiaSandesh Patil, Dileep Kadam, Nicky Mehtani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 9, 2024
Clinical Outcomes in Children With Human Immunodeficiency Virus Treated for Nonsevere Tuberculosis in the SHINE TrialChishala Chabala, Eric Wobudeya, Marieke M van der Zalm, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2018
Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis TreatmentOmamah Alfarisi, Vidya Mave, Sanjay Gaikwad, et al.
The Lancet. Global Health|June 8, 2026
Inclusion of young adolescents in policy development for new tuberculosis vaccinesMark Hatherill, Rebecca A Clark, Leonardo Martinez, et al.
Pageof 15